Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-06-14 @ 2:44 PM
Study NCT ID:
NCT00079105
Status:
COMPLETED
Last Update Posted:
2017-03-30
First Post:
2004-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
Sponsor:
Newcastle-upon-Tyne Hospitals NHS Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000354225
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None